Publicaciones en colaboración con investigadores/as de City Hospital (31)

2013

  1. Interleucina 6 y proteína C reactiva ultrasensible para la predicción de la evolución clínica en síndromes coronarios agudos sin elevación del segmento ST

    Revista Espanola de Cardiologia, Vol. 66, Núm. 3, pp. 185-192

  2. Oral anticoagulation improves the prognosis of octogenarian patients with atrial fibrillation undergoing percutaneous coronary intervention and stenting

    Age and Ageing, Vol. 42, Núm. 1, pp. 70-75

2011

  1. Influence of cardiac resynchronization therapy on indices of inflammation, the prothrombotic state and tissue remodeling in systolic heart failure: A pilot study

    Thrombosis Research

2010

  1. Effects of atorvastatin 80 mg daily on indices of matrix remodelling in 'high-risk' patients with ischemic heart disease

    International Journal of Cardiology, Vol. 139, Núm. 1, pp. 95-97

  2. The prognostic value of biomarkers after a premature myocardial infarction

    International Journal of Cardiology, Vol. 143, Núm. 3, pp. 249-254

2009

  1. Antithrombotic therapy use for patients with atrial fibrillation undergoing percutaneous coronary intervention: New data in an area of limited evidence

    Europace

  2. Biomarkers of pathophysiology in hypertrophic cardiomyopathy: Implications for clinical management and prognosis

    European Heart Journal, Vol. 30, Núm. 2, pp. 139-151

  3. Efficacy and safety of drug-eluting stent use in patients with atrial fibrillation

    European Heart Journal, Vol. 30, Núm. 8, pp. 932-939

  4. Impact of chronic kidney disease on major bleeding complications and mortality in patients with indication for oral anticoagulation undergoing coronary stenting

    Chest, Vol. 135, Núm. 4, pp. 983-990

  5. Influence of electrical cardioversion on inflammation and indexes of structural remodeling, in persistent atrial fibrillation

    International Journal of Cardiology, Vol. 132, Núm. 2, pp. 227-232

2008

  1. Anaemia as predictor of gastrointestinal bleeding in atrial fibrillation patients undergoing percutaneous coronary artery stenting

    QJM

  2. Factor VII -323 decanucleotide D/I polymorphism in atrial fibrillation: Implications for the prothrombotic state and stroke risk

    Annals of Medicine, Vol. 40, Núm. 7, pp. 553-559

  3. Increased major bleeding complications related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting

    Chest, Vol. 134, Núm. 3, pp. 559-567

  4. Is thrombogenesis related to residual platelet function in ischaemic heart disease?

    European Heart Journal

  5. Mortality in patients with atrial fibrillation: Improving or not?

    Europace

  6. The impact of statin use on atrial fibrillation

    QJM, Vol. 101, Núm. 11, pp. 845-861

2007

  1. Common carotid artery intima-media thickness and intracranial pulsatility index in non-ST-elevation acute coronary syndromes

    Cerebrovascular Diseases, Vol. 24, Núm. 4, pp. 338-342

  2. Matrix metalloproteinase-1 and its inhibitor, TIMP-1, in systolic heart failure: Relation to functional data and prognosis

    Journal of Internal Medicine, Vol. 262, Núm. 3, pp. 385-392

  3. Plasma angiogenin levels in acute coronary syndromes: Implications for prognosis

    European Heart Journal, Vol. 28, Núm. 24, pp. 3006-3011

2006

  1. Growth hormone therapy and the heart

    American Journal of Cardiology, Vol. 97, Núm. 7, pp. 1097-1102